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Abstract
Monocytes and neutrophils are important players in the innate immune response and cooperate during infection and
inflammation. In our study we analyzed the effects of neutrophil degranulation products (polymorphonuclear granulo-
cytes degranulation products, PMN-DGP) on the activation, the adhesion and the migration of three bovine monocyte
subsets, as well as their effects on monocyte-macrophage differentiation. Cross-linking of surface CD18 molecules on
bovine PMN resulted in the release of primary, secondary and tertiary granules as well as of secretory vesicles. PMN-
DGP induced a significant Ca2+-influx in classical (classical monocytes, cM) and intermediate monocytes (intermediate
monocytes, intM) but not in non-classical monocytes (non-classical monocytes, ncM). A selective and up-regulated
expression induced by PMN-DGP was only seen for CD11a and CD31 on intM. PMN-DGP induced a selective migration
of intM in vitro. The presence of PMN-DGP during the differentiation of cM or intM into macrophages resulted in
increased expression of membrane CD163 and reduced expression of MHC-II molecules. PMN-DGP-derived macro-
phages produced more IL-12 and IL-10 and showed enhanced phagocytosis and ROS production capacities. In conclusion,
PMN-DGP selectively attract bovine intM and skew the functional maturation of cM and intM.
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Introduction
Monocytes and neutrophils are important players in the
immune response and cooperate during infection and
inflammation. Blood monocytes are a heterogeneous
population of circulating cells with distinct phenotypic
and functional properties.1,2 Based on the cell surface
expression of CD14 and CD16, human1 and bovine2
monocytes are subdivided into classical (cM, CD14++
CD16-), intermediate (intM, CD14++ CD16+) and
non-classical (ncM, CD14+ CD16++) monocyte subsets.
Recent studies have shown that human and mouse
ncM in the steady-state crawl along the endothelium of
blood vessels and thereby take a patrolling function of
healthy tissues.3,4 In response to tissue damage or infec-
tion, these patrolling monocytes have been shown to
rapidly migrate out of the circulation and invade the
damaged site. However, this early efflux of patrolling
ncM has been shown to be transient and these cells are
rapidly replaced by recruited neutrophils.5,6
Early recruited neutrophils are believed to contrib-
ute to the recruitment of a second wave of monocytes
by several mechanisms including the release of neutro-
phil granule proteins.7-9 Recent research in human and
mouse provides evidence for the importance of PMN
granule proteins in the interaction with distinct mono-
cyte subsets.8 It has been demonstrated that PMN-
DGP specifically induce the adhesion and recruitment
of human and murine classical monocytes.7,10
During the migration from blood to tissue, PMN
sequentially release their different granule types, via
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which they communicate with other immune cells, in
particular monocytes and macrophages.11–15 These
granule types, stored in 4 different compartments,
differ in their ability to be mobilized. Secretory ves-
icles have been shown to be released upon the
interaction of neutrophil with endothelial cells, tertiary
granules are discharged during neutrophil trans-
endothelial migration. Being only released once the
neutrophil has been activated in the extravascular
tissue, primary and secondary granules are the last
granule types released.16
Following extravasation, the differentiation of
monocytes into macrophages can be guided by different
local mediators like cytokines, chemokines and micro-
bial products resulting in different functional macro-
phage subtypes.17 Recent studies in human have
revealed a polarizing effect of degranulation products
of human neutrophils on the differentiation of human
monocytes into macrophages.18
As bovine monocyte subsets display distinct func-
tional differences compared to their human and
murine counterparts,2,19 we addressed the question
whether bovine monocyte subsets differ in their respon-
siveness to PMN-DGP.
Material and methods
All procedures involving animals were carried out in
accordance with German legislation on animal welfare.
The commissioner for animal welfare at the University
of Veterinary Medicine, Hannover, Germany, approved
the mentioned procedures and permission was granted by
the Niedersächsisches Landesamt für Verbraucherschutz
und Lebensmittelsicherheit (LAVES).
Animals and blood separation
Blood was obtained from non-pregnant, non-lactating
healthy German Holstein cows (10 cows aged between
3–14 yr) housed in the Clinic for Cattle, University of
Veterinary Medicine, Hannover, Germany. Used ani-
mals were not within the transition period. Blood was
drawn into heparinized vacutainer tubes from the vena
jugularis externa.
Separation of bovine mononuclear
cells (MNC) and neutrophils (PMN)
Bovine MNC and PMN were separated according to
Sipka et al.20 Briefly, blood was layered on Ficoll-
Isopaque (PAA, Pasching, Austria) and centrifuged at
10C for 30min at 1000 g. The interphase containing
MNC was washed three times in PBS (500 g, 200 g and
100 g, 4C). To separate bovine PMN, the PMN-
erythrocyte containing phase was suspended in distilled
water for 20 s and adding double concentrated PBS
restored tonicity. This was repeated (usually twice)
until complete erythrolysis. PMN purity assessed flow
cytometrically according to their FCS/SSC properties
always exceeded 90%. The mean viability of PMN as
determined by exclusion of propidium iodide (2 mg/ml,
Calbiochem, Germany) ranged 92% 4%. PMN were
finally suspended in Hank’s balanced salt solution
(HBSS) at 5 106 cells/ml.
Flow cytometric analysis of adhesion
molecules on monocyte subsets
Peripheral blood mononuclear cells (4 105) from
healthy cows were incubated with mAbs specific for
bovine CD62L (clone CC32, 1:100 final), bovine
CD11b (clone CC126, 1:100 final), sheep CD31 (clone
CO.3E1D4, 1:100 final), human CD49d (clone HP2/1,
1:100 final), bovine CD18 (clone HuH82A, 1:100 final)
(all from AbD Serotec; cross-reactive with homologous
bovine molecules) or bovine CD11a (clone HUH73A;
Kingfisher Biotech, USA, 1:100 final) in PBS contain-
ing BSA (5 g/l) and NaN3 (0.1 g/l). After 30min incu-
bation (4C), cells were washed once and incubated
(30min in the dark, 4C) with a secondary RPE-
conjugated goat anti-mouse IgG Ab (IgG, Clone pAK,
Dianova). Labeled cells were washed once and incubated
with human CD14 Ab (clone TÜK4, Alexa Fluor 647,
1:50 final) and human CD16 Ab (clone KD1, FITC,
1:200 final). After 30min in the dark (4C), labeled
cells were washed once and analyzed flow cytometrically
(BD Accuri C6 flow cytometer, BD Biosciences). Dead
cells were excluded from the analysis by adding propidium
iodide (PI, 2mg/ml). At least 100000 MNC or 20000
monocytes were collected and analyzed with the CFlow
Software, Version 1.0.264.15 (BD Biosciences).
Degranulation of bovine neutrophils
For the preparation of PMN-DGP, degranulation was
induced through Ab cross-linking of the integrin
b2-chain CD18 as described before.21 Isolated bovine
PMN were incubated with murine mAbs against CD18
(2 lg per 106 PMN). We first tested three different
clones of primary CD18-specific mAbs for their ability
to activate bovine PMN upon cross-linking with a goat
anti-mouse IgG F(ab0)2. MAb clones tested were:
mouse anti-dog CD18 (clone CA1.4E9; AbD Serotec)
and mouse anti-bovine CD18 (clone HuH82A and
BAQ30A; Kingfisher, USA). After incubation for
30min at room temperature (RT, 20C), cells were
washed twice to remove unbound Ab and were sus-
pended in HBSS. Pretreated PMN were then subjected
to CD18 cross-linking by addition of goat F(ab0)2 anti-
mouse IgG (diluted 1/20; Jackson ImmunoResearch
Laboratories). Alternatively, separated PMN were sti-
mulated with ionomycin (1 mg/ml, Sigma chemicals).
After 10min incubation at 37C PMN were centrifuged
(300 g, 10min) and cell-free supernatant containing
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PMN-DGP was collected and stored at –20C until use.
For shape-change analysis (change of forward scatter),
PMN were suspended in HBSS and analyzed flow cyto-
metrically [at least 30.000 viable PMN (PI negative)
were acquired, BDAccuriTM C6 flow cytometer, BD
Biosciences].
Analysis of PMN degranulation
For the analysis of neutrophil degranulation the
marker enzymes myeloperoxidase (MPO), lactoferrin,
and alkaline phosphatase were assessed in the super-
natant of activated neutrophils as markers of azurophi-
lic, specific and tertiary granules, respectively. The
release of PMN secretory vesicles was analyzed flow
cytometrically (at least 30.000 viable PMN were
acquired) by determining CD16 expression on activated
neutrophils after labeling the cells with a murine mAb
specific for CD16 (see below). For determining alkaline
phosphatase enzymatic activity, 50 ml PMN super-
natant per well of a 96 well ELISA plate was incubated
with 50 ml of p-nitrophenyl phosphate (pNPP;
Interchim, France) solution (1mg/ml in assay buffer:
100mM Tris-HCl, pH9.5, 100mM NaCl, 5mM
MgCl2). After 15min incubation at RT, the reaction
was stopped by the addition of 50 ml of 2N NaOH,
and the plates were read in an ELISA microplate
reader (ELX 800, BioTek, Germany) at 405 nm. The
activity of myeloperoxidase (MPO) was determined
according to a previously described method.22 Briefly,
50 ll PMN supernatant per well of a 96 well ELISA
plate was incubated with 100 ll/well peroxidase sub-
strate buffer (33.3mmol/l citric acid, 66.7mmol/l
NaH2PO4, pH5.0) supplemented with 130 mg/ml 3,3’,
5,5’-tetramethylbenzidine (TMB, Sigma, Germany) and
0.01% (v/v) H2O2 (Sigma-Aldrich, Germany). After
20min at RT in the dark the addition of 75 ll 0.5M
H2SO4 stopped the reaction. Optical densities were read
in an ELISA microplate reader (ELX 800, BioTek,
Germany) at 450 nm and 630 nm.
For measuring lactoferrin release in the cell-free
neutrophil supernatants a commercially available
ELISA kit for bovine lactoferrin (Bovine Lactoferrin
ELISA Quantitation Set, Bethyl Laboratories,
Montgomery, TX) was used. Briefly, 100ll of diluted
coating Ab (4mg/ml in coating buffer: 50mM carbo-
nate-bicarbonate, pH9.6) was added to each well of
96-well ELISA-plate and incubated for 1 h. Plates were
washed five times with phosphate buffer [2.5mmol/l
NaH2PO4, 7.5mmol/l Na2HPO4, 145mmol/l NaCl,
0.1% (v/v) Tween 20, pH7.2] and each well was filled
with 100ll of the cell–free supernatant from stimulated
PMN. Serial dilutions of recombinant bovine lactoferrin
were included in each assay to construct a standard
curve. After incubation (1h, RT) plates were washed
five times with phosphate buffer and wells were filled
with 100ll of diluted horseradish peroxidase (HRP)
detection Ab (goat anti bovine lactoferrin). After 1 h at
RT the plates were washed and subsequently filled with
75ll/well peroxidase substrate buffer (33.3mmol/l citric
acid, 66.7mmol/l NaH2PO4, pH5.0) supplemented with
130mg/ml TMB and 0.01 % (v/v) H2O2 (all chemicals
from Sigma-Aldrich, Germany). After 20min at RT
in the dark addition of 75ll 0.5M H2SO4 to each
well stopped the reaction. Optical densities were read
in an ELISA microplate reader (ELX 800, BioTek,
Germany) at 450nm and 630nm. Bovine lactoferrin
concentrations were calculated by referring to the stand-
ard curve.
Separation of bovine monocyte subsets
Bovine monocyte subsets were separated as described
recently.2 Briefly, after density gradient separation of
heparinized blood, mononuclear cells were labeled
with a FITC-conjugated CD16-specific Ab (clone
KD1, AbD Serotec, 1:30 final) for 15min (4C) and
subsequently with anti-FITC MultiSort MicroBeads
(Anti-FITC MultiSort Kit; Miltenyi Biotec, 8 ml/1
107 MNC for 20min, 4C) to separate MNC into a
CD16-positive fraction (containing intM and ncM)
and a CD16-negative fraction (containing cM and
lymphocytes) using a magnetic column. To release the
anti-FITC MultiSort MicroBeads from the selected
CD16-positive fraction, cells were incubated with the
MultiSort release reagent (included in the anti-FITC
MultiSort Kit) for 10min. CD16-positive cells (posi-
tively selected) and CD16-negative cells (in the
flow throw) were subsequently incubated with anti-
CD14 MicroBeads (Miltenyi Biotec, 10 ml/1 107 cells
for 20min, 4C) and separated according to the manu-
facturer’s instructions into 3 monocyte subsets.
CD14-positive cells were positively selected from the
CD16-negative fraction (cM) and the CD16-positive
fraction (intM). Remaining cells in the flow throw of
the CD16-positive fraction presented ncM being
CD14-negative and CD16-positive. All steps of mono-
cyte subset isolation were performed at 4C. After each
labeling step, the cells were washed with PBS-EDTA
(300 g, 10min). Negatively and positively selected
cells, being already labeled with CD16-FITC
Abs during the separation process, were checked flow
cytometrically for their viability and purity after label-
ing the cells with a PE-conjugated mouse anti
bovine CD14 mAb (clone TÜK4, AbD Serotec) and
adding propidium iodide (2 mg/ml). This separation
procedure yielded a purity of 94.9 % 5.4% for cM,
89.9% 4.5% for intM and 93.3% 2.2% for ncM.
The mean viability was 92% 5% for all subsets.
For the separation of CD14-positive monocytes
(including cM and intM) bovine MNC were incubated
with CD14-MicroBeads (Miltenyi Biotec) and MACS-
separation was performed according to the manufac-
turer’s instructions.
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Ca2+ influx in monocyte subsets
Ca2+ influx in bovine monocyte subsets was analyzed
according to Hussen et al.19 Briefly, bovine MNC in
PBS were labeled with mouse anti-bovine CD14-
Alexa647 (Tük4, 1:125 final) and mouse anti human
CD16-PE (KD1, 1:200 final) to define monocyte sub-
sets (all Abs were from AbD Serotec). Cells were
washed two times in 5ml of membrane immunofluor-
escence (MIF) buffer [PBS containing BSA (5 g/l) and
NaN3 (0.1 g/l)] (300 g, 4min, 4
C) and suspended in
HBSS without phenol red (5 106/ml). Cell suspension
(1ml) was incubated with 2 ml of the calcium-sensitive
fluorochrome Fluo 4 (final 1:10 in PBS, 100 nmol/l,
Invitrogen, Karlsruhe, Germany) (30min, 37C).
After two washings in HBSS (300 g, 6min, RT) cells
were adjusted to 5 106/ml and 100 ml was transferred
to 1.5ml Eppendorf tubes containing propidium iodide
(100 ml, 2 mg/ml) to exclude dead cells. Green fluores-
cence was monitored flow cytometrically. Twenty s
after start of measurement (baseline), cells were stimu-
lated with 100 ml PMN supernatant and flow cytometric
assessment continued for 2min. The response towards
ionomycin (1 mg/ml final, Sigma-Aldrich, Germany)
served as a positive control, supernatant from PMN
cultures in HBSS served as negative control.
In forward (FSC) versus side scatter (SSC) dot plots,
MNC were gated based on their characteristic scatter
properties and monocytes subsets were defined by gates
in a CD14/CD16 dot plot. Green fluorescence (FL1)
was plotted against time. Using a quadrant, a horizon-
tal line was adjusted above the FL1 baseline. Directly
after addition of stimuli, the percentage of cells above
the horizontal line served as a measure for Ca2+ influx
in bovine monocytes.
In vitro migration assay of monocyte subsets
Monocyte migration was evaluated in a transwell
system (6.5mm-diameter polycarbonate membranes
with 5.0mm-diameter pores; 24 well plate, Corning).
MACS-separated bovine monocyte subsets (2 105 in
200 ml DMEM medium without serum) were placed in
the upper chambers. The lower chambers were filled
with 500 ml PMN supernatant. After 4 h incubation at
37C, non-migrating cells were collected from the upper
and migrating cells from the lower chamber. After
counting the cells flow cytometrically,23 migration
rates24 [the percentage of migrating cells in the lower
chamber of total recovered cells (sum of cells in the
lower and the upper chamber)] were calculated and pre-
sented for each subset.
Generation of monocyte-derived macrophages
(MdM) in vitro
Monocyte subsets after MACS separation were
suspended in Iscové medium supplemented with
100U/ml penicillin/streptomycin and 10% FCS,
adjusted to 2 105 cells/ml and seeded in 24-well
plates (2 105 cells/well, Fisher Scientific GmbH,
Schwerte, Germany) for 24 h at 37C (5% CO2 in
air). After this resting period, culture medium was
removed and cells were further incubated without or
with cell-free supernatant containing PMN-DGP
throughout the in vitro culture period. On d 4 of cul-
ture, PMN-DGP was removed and fresh medium was
added to the cells. Day 4 MdM were further incubated
for 4 h at 37C (5% CO2 in air) and the supernatant




Monocyte-derived macrophages (2 105) were incu-
bated with the fluorochrome-conjugated mAbs, mouse
anti porcine CD163 (clone 2A10/11, 1:50 final) and
mouse anti-ovine MHC-II (clone 37.68, 1:40 final) in
PBS containing BSA (5 g/l) and NaN3 (0.1 g/l). Both
Abs are cross-reactive with homologous bovine mol-
ecules (AbD Serotec). After 30min in the dark (4C),
labeled cells were washed once and analyzed flow cyto-
metrically. Dead cells were excluded from the analysis
by adding propidium iodide (PI, 2 mg/ml, Calbiochem,
Germany). At least 10 000 macrophages were collected
and analyzed with the CFlow Software, Version
1.0.264.15 (BD Biosciences).
Cytokine ELISA
Previously described cytokine ELISA procedures were
used to detect bovine IL-1225 and IL-1026 in macro-
phage culture supernatants. Briefly, 96-well microtiter
plates were coated with 100 ml (4 mg/ml) mouse anti-
bovine IL-12 (clone CC301, AbD Serotec) or IL-10
(clone CC318, AbD Serotec) overnight (18 h) at 4C.
Plates were washed with PBS Tween 20 (0.05%) and
blocked with 150 ml fish skin gelatin (2%) for 1 h at
25C. Culture supernatants (100ml) were added to the
plates. Bovine IL-12 or IL-10 protein standard
(Innovative research, USA) was serially diluted and
added (100 ml) to the wells. Plates were incubated for
1 h at 25C. After washing with PBS Tween 20 (0.05%),
plates were incubated with 75 ml (2 mg/ml) of biotin-
labeled mouse anti-bovine IL-12 (clone CC326, AbD
Serotec) or biotin-labeled mouse anti-bovine IL-10
(clone CC320, AbD Serotec) at 37C for 1 h. Plates
were washed, and streptavidin HRP (1:1000 in blocking
buffer, GE Healthcare Lifesciences, UK, 100 ml) was
added. After 1 h at RT the plates were washed and
subsequently filled with 75 ll/well peroxidase substrate
buffer (33.3mmol/l citric acid, 66.7mmol/l NaH2PO4,
pH5.0) supplemented with 130mg/ml TMB and 0.01%
(v/v) H2O2 (all chemicals from Sigma-Aldrich,
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Germany). After 20min at RT in the dark the add-
ition of 75 ll of 0.5M H2SO4 to each well stopped the
reaction. Optical densities were read in an ELISA
microplate reader (ELX 800, BioTek, Germany) at
450 nm and 630 nm. Bovine IL-12 and IL-10 concentra-
tions were calculated by referring to the standard
curves.
Phagocytosis assay
Phagocytosis was analyzed by flow cytometry after
incubation of macrophages with FITC-labeled
Escherichia coli. Labeling of E. coli was performed as
described previously27 with modifications. Briefly, E.
coli (Institute of Microbiology, University of
Veterinary Medicine, Hannover, Germany) were
inoculated into broth and incubated overnight at
37C in a shaker. The bacteria were washed three
times in PBS and fixed for 1 h at 4C with 4% paraf-
ormaldehyde in PBS. Fixed bacteria were incubated for
12 h with FITC (Sigma-Aldrich, St. Louis, Missouri,
USA) (25mg/ml). Bacterial cell count and labeling effi-
ciency ( 80%) were determined flow cytometrically.
Day 4 macrophages, after washing off the PMN-
DGP, were plated in 96 well plates (1 105/well) and
incubated with non-opsonized bacteria (25 bacteria/
cell) for 40min (37C, 5% CO2). After incubation,
cells were washed (300 g for 10min) with PBS. To
exclude dead macrophages and adherent bacteria
from the analysis, PI (2 mg/ml final), which is unable
to pass through the plasma membrane of viable phago-











































Figure 1. Different activating capacities of CD18-specific mAbs for bovine PMN. Bovine PMN were incubated with three different
mouse mAbs specific for CD18. Bound mAbs were cross-linked after addition of goat anti-mouse IgG F(ab0)2 for 10 min. Alternatively,
PMN were stimulated with ionomycin for 10 min or left completely untreated. PMN activation was analyzed by flow cytometric
assessment of their shape change after drawing a gate to exclude doublets (SSC-A vs. SSC-W). (a) Representative dot plots of one
animal showing a shift in the FSC of activated PMN resulting in a higher percentage of cells in the lower right quadrant. (b) The mean
forward scatter (FSC A) of PMN was assessed and data of 7 tested animals were presented as mean SEM (*¼ P< 0.05 in com-
parison to HBSS control).
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was defined flow cytometrically as the percentage of
green fluorescing cells among viable cells. At least
20.000 viable macrophages were acquired.
Generation of reactive oxygen species (ROS)
ROS generation was induced in 96-well round-bottom
microtiter plates (Corning, NY, USA). Day 4 macro-
phages (1 105/well) in RPMI medium were incubated
with killed non-opsonized E. coli bacteria. Day 4
macrophages, after washing off the PMN-DGP, were
stimulated with bacteria (50 bacteria/cell) for 15min
(37C, 5% CO2). For the detection of ROS, dihydror-
hodamine 123 (DHR 123, Mobitec, Goettingen,
Germany) was added to the cells (750 ng/ml final).
After incubation, cells were washed with RPMI
medium and suspended in medium containing PI
(2 mg/ml final) to exclude dead cells from the analysis.
The relative amount of generated ROS was determined
flow cytometrically by the median green fluorescence
intensity of gated cells after acquisition of 20 000
viable macrophages.
Statistical analyses
Statistical analysis was carried out using the software
Prism (GraphPad software). Results are expressed as
means S.E. of the mean (SEM). Differences between
means were tested with t-test (comparison between two
groups) or the one-factorial analysis of variance
(ANOVA) (comparison between more than two
groups) and Bonferroni’s correction for normally dis-
tributed data. Results were considered statistically sig-









































































































Figure 2. Analysis of PMN degranulation products. Bovine PMN were pretreated with mouse mAb against CD18 and were then
subjected to CD18 cross-linking through addition of goat anti-mouse F(ab0)2 for 10 min. Alternatively, PMN were stimulated with
ionomycin for 10 min. The release of PMN secretory vesicles was analyzed flow cytometrically by determining CD16 expression (a) on
activated neutrophils (n¼ 5 animals) after labeling the cells with a murine mAb specific for CD16.The enzymatic activity of alkaline
phosphatase (b) was determined in the supernatant of degranulated PMN by colorimetric assays (n¼ 6 animals, optical densities, OD).
Bovine lactoferrin release (c) in the supernatants of degranulated PMN (n¼ 6 animals) was measured by ELISA. Myeloperoxidase
enzymatic activity (d) was determined in the supernatant of degranulated PMN by colorimetric assays (n¼ 6 animals, optical densities,
OD). All data are shown as mean SEM (*¼ P< 0.05 in comparison to HBSS control).
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Results
Cross-linking of CD18 on bovine neutrophils
induces their degranulation
To collect PMN-DGP, PMN-degranulation was
induced through Ab cross-linking of surface CD18
molecules using a CD18 primary Ab and a secondary
goat anti-mouse IgG F(ab0)2-fragment.21 Cellular acti-
vation of PMN was analyzed by flow cytometric assess-
ment of shape change.28 Shape change was assessed as
the change in median FSC of PMN. Based on side scat-











































Figure 3. PMN-DGP-induced Ca2+-influx in bovine monocyte subsets. A) Bovine mononuclear cells (MNC) were stained with mAbs
specific for CD14 and CD16 and were preloaded with Fluo-4. (a) Green fluorescence (FL1) was plotted against time. For gated bovine
monocyte subsets, Ca2+influx in classical (cM), intermediate (intM) and non-classical monocytes (ncM) was measured as the per-
centage of cells above the horizontal line after addition of the stimulus (arrows). (b) The percentage of responding monocytes towards
HBSS (supernatant from PMN cultures in HBSS, negative control), ionomycin (positive control) or PMN-DGP is presented as
mean SEM (n¼ 6 animals; *¼ P< 0.05 in comparison to HBSS control).
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(SSC-A vs. SSC-W). While no significant differences
could be seen between the median FSC of PMN in
HBSS (1.98 0.01 106) and those of PMN incubated
with the primary CD18 Ab alone (1.99 0.02 106)
or with the secondary goat anti-mouse IgG F(ab0)2
Ab alone (1.99 0.01 106), cross-linking of CD18
Ab with the secondary goat anti-mouse IgG F(ab0)2
Ab resulted in increased median FSC (2.19 0.02
 106) indicating a shape change of bovine PMN
(Figure 1a).
Looking for a CD18 Ab clone for the functional
activation of PMN, we first tested three different
clones of the primary CD18-specific mAb for their abil-
ity to activate bovine PMN upon cross-linking with a
goat anti-mouse IgG F(ab0)2. While the cross-linking of
the anti-canine CD18 Ab did not induce a shape change
of bovine PMN, the cross-linking of two bovine CD18-
specific Abs induced a shape change of bovine PMN
(P< 0.001), which was comparable to activation with




























































Figure 4. Flow cytometric analysis of adhesion molecules on bovine monocyte subsets. Bovine MNC were labeled with mouse
mAbs specific for CD14 and CD16 to define bovine monocyte subsets. MNC were also labeled with mouse mAbs specific for CD62L
(a), CD11b (b), CD31 (c), CD18 (d), CD11a (e) or CD49d (f) and labeled cells were analyzed on the flow cytometer. After dead
cell exclusion with propidium iodide, gates were made on cM, intM or ncM subsets in a CD14 versus CD16 dot plot. Mean
fluorescence intensities of adhesion molecules were determined for gated bovine cM, intM and ncM (mean SEM, n¼ 13 animals;
*¼ P< 0.05).
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induce PMN-degranulation, the clone HuH82A was
chosen, which also induced more MPO release than
the other two clones (data not shown).
In opposite to the incubation of PMN in HBSS, with
the primary CD18 Ab alone or with the secondary goat
anti-mouse IgG F(ab0)2 Ab alone, cross-linking of CD18
on the surface of PMN resulted in the up-regulation
(P< 0.05) of PMN CD16 expression (Figure 2a).
Supernatants of cross-linked PMN showed an increase
in the enzymatic activity of alkaline phosphatase
(Figure 2b) and MPO (Figure 2d) (P< 0.5). Also, the
concentration of bovine lactoferrin was higher in super-
natants of cross-linked PMN in comparison to super-
natant of PMN in HBSS or PMN incubated with the
primary CD18 Ab alone or with the secondary goat
anti-mouse IgG F(ab0)2 Ab alone (Figure 2c). As a posi-
tive control, stimulation of PMN with ionomycin resulted
in upregulation of CD16 on PMN, increased alkaline
phosphatase and MPO enzymatic activity of the super-
























































Figure 5. PMN-DGP-induced modulation of adhesion molecule expression on bovine monocyte subsets. Bovine MNC were
incubated without or with bovine PMN-DGP for 2 h. Incubated cells were then labeled with mouse mAbs specific for CD14 and CD16
to define bovine monocyte subsets. MNC were also labeled with mouse mAbs specific for CD62L (a), CD11b (b), CD31 (c), CD18
(d), CD11a (e) or CD49d (f) and labeled cells were analyzed on the flow cytometer. MFI were determined for gated bovine cM,
intM and ncM. MFI values of cells in control set ups (MNC in RPMI medium) were set to 100 % (mean SEM; n¼ 13 animals;
*¼ P< 0.05).
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the supernatant of stimulated PMN (P< 0.05)
(Figure 2a–d). The detection of alkaline phosphatase,
lactoferrin and MPO in the cell-free supernatants of
cross-linked PMN indicates the release of their tertiary,
secondary and primary granules. We subsequently used
these cell-free supernatants as PMN-DGP to study their
potential to modulate the activation, the migration and
the differentiation of bovine monocyte subsets.
Neutrophil secretions induce Ca2+ mobilization in
bovine classical and intermediate monocyte subsets
To see whether PMN-DGP have an activating potential
for distinct monocyte subsets we analyzed Ca2+ mobiliza-
tion in bovine cM, intM and ncM after stimulation with
PMN-DGP. Compared to supernatant of PMN in HBSS,
supernatants of CD18 cross-linked neutrophils (PMN-
DGP) induced a comparable rise of intracellular Ca2+ in
bovine classical and intermediate monocytes (Figure 3,
P< 0.05). Notably, non-classical monocytes did not
respond towards PMN-DGP (Figure 3), although all
monocyte subpopulations responded in the same way
towards ionomycin stimulation. The contaminating
F(ab0)2 fragment of the secondary, cross-linking Ab did
not exhibit a significant Ca2+ influx-inducing potential
(3.1 0.3, mean SEM) in bovine monocytes in compari-
son to supernatant from non-stimulated PMN cultured in
HBSS (2.0 0.4, mean SEM).
Neutrophil secretions modulate the expression
of adhesion molecules on bovine monocyte subsets
Looking for a possible role of PMN-DGP in the adhesion
and migration of bovine monocyte subsets, the surface
expression of adhesion molecules on bovine monocyte sub-
sets was determined flow cytometrically. Classical mono-
cytes and intM showed a 3-4 times higher expression (mean
fluorescence intensities, MFI) of CD62L and CD11b com-
pared to ncM (P< 0, 05, Figure 4). The surface expression
density (MFI) of CD11a and CD49d was lowest on cM,
higher on intM and highest on ncM (P< 0.05). CD31 and
CD18 were higher expressed (MFI) on intM compared to
cM or ncM (P< 0.05; Figure 4).
The incubation of bovine monocytes with PMN-
DGP resulted in the up-regulation of CD11a and
CD31 on intM (P< 0.005). The expression of CD18,
CD11b, CD49d or CD62-L was not affected
(P> 0.05) by PMN-DGP (Figure 5).
Neutrophil secretions induce a selective migration
of bovine intermediate monocytes in vitro
To investigate the role of PMN in the selective recruit-
ment of distinct monocyte subsets, the migration of
bovine monocyte subsets toward PMN-DGP was eval-
uated using a transwell migration system. Although cM
showed a higher random migration rate (46% 4%;
meanSEM) toward HBSS, no increase in their
migration rate (56% 10%; mean SEM) could be
induced by PMN-DGP (P> 0.05, Figure 6a). For
ncM, with lower random migration rates about (22%
 9%; meanSEM), PMN-DGP showed no effect
(P> 0.05) on the migration rates of ncM (24% 9%;
meanSEM). IntM showed the lowest migration rates
toward HBSS (14% 6%; meanSEM) and displayed
a enhanced migration (32% 7%; meanSEM)
towards PMN-DGP (P< 0.05) (Figure 6).
Neutrophil secretions guide the differentiation
of bovine monocytes into macrophages with
a distinct phenotype and cytokine profile
For bovine monocyte subsets responding towards PMN-
DGP (cM, intM), the phenotype of monocyte-derived
macrophages differentiated in the presence of PMN-
DGP was determined by analyzing the surface expres-
sion of CD163 and MHC-II molecules. In the absence of
PMN-DGP during the differentiation, cM-derived and
intM-derived macrophages displayed a similar expres-
sion density of MHC-II molecules. CD163 expression
was higher on cM-derived macrophages (P< 0.05,
Figure 7). Compared to the differentiation in Iscové
medium, the presence of PMN-DGP during the differ-
entiation of monocytes into macrophages enhanced the
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Figure 6. PMN-DGP-induced migration of bovine monocyte
subsets. MACS-separated bovine monocyte subsets were ana-
lyzed in a transwell system. Lower chambers were filled with
500 ml HBSS or PMN degranulation products (PMN-DGP). After
4 h non-migrating (upper chamber) and migrating cells (lower
chamber) were counted flow cytometrically. A) Migration rates
of monocyte subsets were calculated as the percentage of
migrating cells of total cells (sum of cells in the lower and upper
chamber). Data are presented as mean SEM (n¼ 5 animals;
*¼ P< 0.05).
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MHC-II on macrophages differentiated from both
monocyte subsets (P< 0.05) (Figure 7).
Both cM- and intM-derived macrophages generated
in the presence of PMN-DGP secreted more IL-12 and
IL-10 than macrophages differentiated in Iscové
medium (P< 0.05) (Figure 8). The tendency of PMN-
DGP guided intM-derived macrophages to produce less
IL-10 and IL-12 than cM-derived macrophages was not
significant (Figure 8).
Monocyte-derived macrophages differentiated
in the presence of neutrophil secretions show
enhanced antimicrobial capacities
The results (Figure 7 and 8) showing no differences
between cM- and intM-derived macrophages prompted
us to investigate the antimicrobial capacities of CD14-
positive monocyte-derived macrophages (including the
cM and intM subset). The presence of PMN-DGP
during monocyte differentiation into macrophages
resulted in increased (P< 0.05) percentage of E. coli-
positive macrophages (Figure 9a). Also, the generation
of reactive oxygen species in response to E. coli stimu-
lation was higher (P< 0.001) in macrophages generated
in the presence of PMN-DGP (Figure 9b).
Discussion
Since the monocyte extravasation cascade involves a
series of sequential interactions between monocytes,
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Figure 8. Effect of PMN-DGP on cytokine production of
bovine monocyte-derived macrophages. MACS-separated bovine
cM and intM were differentiated in culture Iscové medium or in
Iscové medium containing PMN-DGP for 4 d in vitro. IL-12 (a) and
IL-10 (b) concentration in culture supernatants were determined
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PMN-DGP: − + − +
Figure 7. Effects of PMN-DGP on the phenotype of bovine
monocyte-derived macrophages. MACS-separated bovine cM
and intM were differentiated in Iscové medium or in Iscové
medium containing PMN-DGP for 4 d in vitro. Day 4 macrophages
were labeled with mAbs specific for MHC class II (a) and CD163
(b). MFI after flow cytometrical analysis are presented as
mean SEM (n¼ 9 animals; *¼ P< 0.05).
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first addressed the expression of adhesion molecules on
bovine monocyte subsets.
Similar to their human and murine counterparts,30
bovine cM showed the highest expression of L-selectin
(CD62L) when compared with intM and ncM subsets.
This is also the case for the CD11b (Mac1) expression
level. Thus, the expression of adhesion molecules on
cM and intM as well as the lower expression of
CD11b and CD62L on ncM is comparable to the
human system.4,30
The crawling behavior of murine and human ncM
along endothelial cells in blood vessels is mediated by
the integrin LFA1 (CD11a).3,4 In addition, the very late
antigen-4 (VLA-4 or CD49d), which promotes mono-
cyte adherence to endothelial vascular cell adhesion
molecule-1 (VCAM-1) was shown to be highest
expressed on human ncM.4,31 The highest expression
level of LFA1 and VLA-4 on bovine ncM suggests a
similar patrolling function of this monocyte subset in
the bovine system.
However, in contrast to human and murine mono-
cytes where the ncM subset was shown to express the
highest level of the platelet endothelial cell adhesion
molecule (PECAM1, CD31),30,32 we found the highest
level of PECAM1 on bovine intM monocytes.
PECAM1 triggers both the adhesion of leucocytes to
endothelial cells and integrin-mediated migration into
surrounding tissues.33,34 Thus, one may speculate that
this molecule primarily contributes to the accumulation
of the bovine intM rather than the cM or ncM subset.
PMN which dominate the early immune response to
acute infection and injury,6,16 contribute to the recruit-
ment of a second wave of monocytes35 by releasing
their preformed PMN granule proteins that initiate
monocyte adhesion and recruitment.10
Although CD18 cross-linking21 resulted in the
release of secretory vesicles, tertiary, secondary, and
primary granules of PMN, this approach takes not
into account that PMN release their granule contents






























Figure 9. Effect of PMN-DGP on the antimicrobial function of bovine monocyte-derived macrophages. MACS-separated bovine
CD14-positive monocytes were differentiated in culture medium (Iscové) or in medium containing PMN-DGP for 4 d in vitro. (a) Day 4
macrophages were incubated with killed, FITC-labeled E. coli. The percentages of phagocytosis-positive cells among viable (PI-negative)
cells were determined flow cytometrically. Data from 3 tested animals were presented as mean SEM. (b) Generation of ROS was
assessed flow cytometrically after incubation of d 4 macrophages with killed E. coli in the presence of DHR-123 for 30 min. Data are
shown as mean SEM (n¼ 3 animals; *¼ P< 0.05).
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monocyte modulations observed here. On the other
hand, the chosen approach minimizes unwanted effects
on monocytes of more natural PMN stimuli, which
would be still present in the supernatants of activated
PMN. The contaminating F(ab0)2 fragment of the sec-
ondary, cross-linking Ab did not exhibit any Ca2+
influx-inducing potential. Therefore, effects of PMN-
DGP on bovine monocytes can be regarded as specific
for PMN granule contents.
Whereas studies in human36 and mice10 indicate the
involvement of neutrophil degranulation products in
the recruitment of classical monocytes nothing is
known about the differential PMN-DGP responsive-
ness of bovine monocyte subsets. PMN-DGP induced
a selective migration of bovine intM in vitro. This is
also supported by the PMN-DGP induced selective
upregulation of CD31 and CD11a on intM.
Interestingly, this migration and adhesion molecule
inducing potential of bovine PMN-DGP was only
observed for intermediate monocytes, although
PMN-DGP induced Ca2+ influx in both classical and
intermediate monocytes. This is roughly in parallel with
the murine system, where stimulation with PMN-DGP
resulted in Ca2+-mobilization in inflammatory mono-
cytes,10 which include both the murine classical and
intermediate monocytes. The lack of a Ca2+ inducing
potential of PMN-DGP for bovine ncM is paralleled by
findings in the human system.1
Following extravasation, monocytes differentiate
into different macrophage populations after condition-
ing by local mediators.17 Having shown via Ca2+influx
induction that both cM and intM are targets of PMN-
DGP, we addressed the question whether PMN-DGP,
when present during the in vitro differentiation, also
guide the differentiation of these monocytes into
macrophages with distinct phenotype and function.
Although the induced up-regulation of CD163 and
the down-regulation of MHC class II on bovine
DGP-differentiated macrophages indicates a M2
phenotype,37 the increased production of the inflamma-
tory cytokine IL-12 as well as the anti-inflammatory
cytokine IL-10 argues against a polarizing effect of
PMN-DGP on monocyte differentiation into macro-
phages as supposed by others.38-40 For instance,
human monocytes were polarized towards the M1
phenotype by the cathelicidin LL-37, a degranulation
product of human neutrophils.18 Whether such effects
are balanced by the actions of other PMN degranula-
tion products or whether the bovine LL-37 homologue
BMAP-27 induces the same kind of polarization is not
known. It may also be, that the PMN-DGP-induced
mixed M1/M2 phenotype of bovine macrophages
depends on a species-specific composition of PMN
granule molecules. This composition differs between
human and bovine neutrophils.35 In addition, bovine
neutrophils contain a unique large granule type,
which is not evident in human cells.41,42 As CD163
was differently expressed on cM- and intM-derived
macrophages generated in the absence of PMN-DGP,
the comparable expression of CD163 between PMN-
DGP-guided cM- and intM-derived macrophages
indicates no selective effect of PMN-DGP on the dif-
ferentiation of bovine cM or intM into macrophages.
As no phenotypic or functional differences could be
seen between PMN-DGP-guided cM- and intM-
derived macrophages, we analyzed the antimicrobial
capacity of macrophages differentiated from bovine
CD14-positive monocytes, including cM and intM, in
presence of PMN-DGP. The enhanced capacity of such
macrophages to phagocytize and to generate reactive
oxygen species is in agreement with a previous study
with human and murine macrophages, where PMN-
DGP enhanced the phagocytosis and the production
of ROS after stimulation with E. coli.43 Thus, although
many direct and indirect antimicrobial activities have
been described for PMN-DGP,44 our results clearly
indicate a direct effect of PMN-DGP on macrophages
rather than a mere opsonization effect.
Conclusion
In conclusion, the selective PMN-DGP induced up-reg-
ulation of adhesion molecules on intM and the migra-
tion inducing potential of PMN-DGP for intM suggests
that degranulating neutrophils take part in the selective
attraction of the bovine intermediate monocyte subset.
PMN-DGP do not polarize monocyte-derived macro-
phages but result in the differentiation towards a mixed
macrophage phenotype with enhanced antimicrobial
functions.
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